Gowling WLG advised AstraZeneca on exclusive option and global license agreement with Pinetree Therapeutics. AstraZeneca has entered into an exclusive option and global license agreement with...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised SixPeaks Bio AG while Lenz & Staehelin acted as Swiss counsel to AstraZeneca. SixPeaks Bio AG has secured USD30 million in Series A...
You must be a Standard 1 Year member to access this content.
Gowling WLG advised AstraZeneca on the agreement. Cooley LLP advised Quell Therapeutics. A collaboration and license agreement has been established between AstraZeneca and biopharmaceutical company Quell...
You must be a Standard 1 Year member to access this content.
Covington & Burling advised AstraZeneca. Skadden represented Centerview Partners LLC, the exclusive financial advisor to CinCor Pharma Inc. Cooley advised CinCor Pharma. CinCor Pharma Inc. (“CinCor”)...
You must be a Standard 1 Year member to access this content.
Gowling WLG advised AstraZeneca on the transaction. AstraZeneca started a collaboration with Scorpion Therapeutics, Inc. (“Scorpion”) to develop precision medicines against previously hard-to-target cancer proteins. Scorpion will...
You must be a Standard 1 Year member to access this content.
Williams & Connolly LLP advised AstraZeneca on the deal. AstraZeneca obtained a trial victory in a high-stakes Hatch-Waxman patent litigation against Mylan Pharmaceuticals Inc. involving three patents covering...
You must be a Standard 1 Year member to access this content.
Sidley Austin LLP advised AstraZeneca China on the deal. AstraZeneca China announced a strategic collaboration with Shanghai Junshi Biosciences Co., Ltd. (Junshi Biosciences). AstraZeneca China will be...
You must be a Standard 1 Year member to access this content.
